Japanese shipping company Nippon Yusen Kabushiki Kaisha pleaded guilty on Monday in Australia‘s federal court to criminal cartel conduct in relation to the transport of vehicles into the country.
The charges, which were brought last Thursday by Australia’s competition watchdog, the Australian Competition and Consumer Commission, could lead to a fine of at least $7.6 million.
“This matter relates to alleged cartel conduct in connection with the transportation of vehicles, including cars, trucks, and buses, to Australia between July 2009 and September 2012,” ACCC Chairman Rod Sims said in a statement. The company had pleaded guilty, the statement said.
It was the first criminal charge laid against a corporation under the Competition and Consumer Act, Sims said, following a law change in 2009 that made cartel conduct a criminal act.
Jason Glynn, the general manager of corporate affairs for Nippon Yusen’s Australian subsidiary, NYK Line (Australia) Pty Ltd, confirmed the guilty plea.
“NYK has co-operated fully with the ACCC during the course of this investigation. NYK will not make any further comment while this matter is before the courts,” he said.
Nippon Yusen’s Tokyo headquarters could not immediately be reached for comment.
The penalty for cartel conduct under Australian competition law is the greater of $A10 million, triple the benefit attributed to the offence, or 10 percent of the corporation’s annual turnover in Australia.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas